Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Katoh

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 9, 2011
Mechanism of drug interaction between a Kampo medicine, byakkokaninjinto, and tetracycline in ratsKotaro Hitoshi, Miki Katoh, Yoshiteru Tanaka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 14, 2010
Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in ratsTakayuki Noda, Fumie Abe, Jun Ueyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2008
Metabolic activation of benzodiazepines by CYP3A4Katsuhiko Mizuno, Miki Katoh, Hirotoshi Okumura, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivoTatsuki Fukami, Miki Nakajima, Ryoko Yoshida, et al.
Pharmacogenetics|April 30, 2004
A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activityHiroyuki Yamanaka, Miki Nakajima, Miki Katoh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2007
Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoformsRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 4, 2005
Expression of human phase II enzymes in chimeric mice with humanized liverMiki Katoh, Tomohito Matsui, Hirotoshi Okumura, et al.
Biological & Pharmaceutical Bulletin|December 22, 2012
A simple liquid chromatography-tandem mass spectrometry method for determination of plasma fentanyl concentration in rats and patients with cancer painTatsuya Hisada, Miki Katoh, Kotaro Hitoshi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2005
In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liverMiki Katoh, Tomohito Matsui, Miki Nakajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 19, 2013
[Preparation of dealcholized onetaxotere®, docetaxel injection formulation and its pharmacokinetics in rats]Katsuhiro Onishi, Ikuto Tsukiyama, Miki Katoh, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 9, 2011
Mechanism of drug interaction between a Kampo medicine, byakkokaninjinto, and tetracycline in ratsKotaro Hitoshi, Miki Katoh, Yoshiteru Tanaka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 14, 2010
Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in ratsTakayuki Noda, Fumie Abe, Jun Ueyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2008
Metabolic activation of benzodiazepines by CYP3A4Katsuhiko Mizuno, Miki Katoh, Hirotoshi Okumura, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivoTatsuki Fukami, Miki Nakajima, Ryoko Yoshida, et al.
Pharmacogenetics|April 30, 2004
A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activityHiroyuki Yamanaka, Miki Nakajima, Miki Katoh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2007
Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoformsRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 4, 2005
Expression of human phase II enzymes in chimeric mice with humanized liverMiki Katoh, Tomohito Matsui, Hirotoshi Okumura, et al.
Biological & Pharmaceutical Bulletin|December 22, 2012
A simple liquid chromatography-tandem mass spectrometry method for determination of plasma fentanyl concentration in rats and patients with cancer painTatsuya Hisada, Miki Katoh, Kotaro Hitoshi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2005
In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liverMiki Katoh, Tomohito Matsui, Miki Nakajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 19, 2013
[Preparation of dealcholized onetaxotere®, docetaxel injection formulation and its pharmacokinetics in rats]Katsuhiro Onishi, Ikuto Tsukiyama, Miki Katoh, et al.
Pageof 8